Literature DB >> 12621017

Functional mapping of regional liver asialoglycoprotein receptor amount from single blood sample and SPECT.

Noriyuki Shuke1, Atsutaka Okizaki, Shuichi Kino, Junichi Sato, Yukio Ishikawa, Chunlei Zhao, Seigo Kinuya, Naoto Watanabe, Kunihiko Yokoyama, Tamio Aburano.   

Abstract

UNLABELLED: The objective of this study was to validate a method for estimating regional liver asialoglycoprotein (ASGP) receptor amount from single blood samples using static SPECT with (99m)Tc-diethylenetriaminepentaacetic acid galactosyl human serum albumin ((99m)Tc-GSA).
METHODS: Based on a 2-compartment nonlinear model, regional ASGP receptor amount could be calculated from total liver ASGP receptor amount (Ro) and regional GSA uptake at a specific time. Because Ro could be estimated from single blood samples using an empiric formula, regional GSA uptake obtained as a SPECT voxel count could be converted to regional ASGP receptor amount by solving a nonlinear model equation. To validate this method, data from 62 patients with chronic liver disease underwent dynamic SPECT (30 rotations per 30 min) and simultaneous multiblood sampling and were analyzed by this method. Ro was calculated as the sum of voxel values of parametric receptor images generated from plasma concentration of GSA at 20 min and of static SPECT images generated by merging dynamic SPECT data (12-20 min). Ro was also estimated by fitting time-activity curves (4-30 min) of plasma and whole liver to the nonlinear model using the nonlinear regression method. Ro obtained from the receptor image was compared with that from curve fitting in relation to the results of hepatic function tests (indocyanine green test, hepaplastin test, and branched-chain amino acids/tyrosine plasma concentration ratio) and Child's classification.
RESULTS: Ros from the 2 methods showed a significant linear correlation (r(2) = 0.938; P < 0.0001; slope = 0.90; y-intercept = 1.5). Both Ros had significant correlations with the results of hepatic function tests (P < 0.001) and differed significantly among the 3 groups of Child's classification (P < 0.0001).
CONCLUSION: The present method could provide a quantitative ASGP receptor image without dynamic data acquisition. This approach could be useful for quantitative evaluation of regional liver function and estimation of residual liver function in hepatectomy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12621017

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  5 in total

1.  Fused 99m-Tc-GSA SPECT/CT imaging for the preoperative evaluation of postoperative liver function: can the liver uptake index predict postoperative hepatic functional reserve?

Authors:  Morikatsu Yoshida; Shinya Shiraishi; Fumi Sakaguchi; Daisuke Utsunomiya; Kuniyuki Tashiro; Seiji Tomiguchi; Hirohisa Okabe; Toru Beppu; Hideo Baba; Yasuyuki Yamashita
Journal:  Jpn J Radiol       Date:  2012-04       Impact factor: 2.374

2.  Significance of (99m)Tc-GSA liver scintigraphy in liver surgery and transplantation.

Authors:  Taku Iida; Shintaro Yagi; Tomohide Hori; Shinji Uemoto
Journal:  Ann Transl Med       Date:  2015-02

3.  Hepatic clearance measured with (99m)Tc-GSA single-photon emission computed tomography to estimate liver fibrosis.

Authors:  Masahiko Taniguchi; Atsutaka Okizaki; Kenji Watanabe; Koji Imai; Koichiro Uchida; Takahiro Einama; Noriyuki Shuke; Naoyuki Miyokawa; Hiroyuki Furukawa
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

4.  A quantitative index measured on ⁹⁹mTc GSA SPECT/CT 3D fused images to evaluate severe fibrosis in patients with chronic liver disease.

Authors:  Morikatsu Yoshida; Shinya Shiraishi; Fumi Sakaguchi; Daisuke Utsunomiya; Kuniyuki Tashiro; Seiji Tomiguchi; Hirohisa Okabe; Toru Beppu; Hideo Baba; Yasuyuki Yamashita
Journal:  Jpn J Radiol       Date:  2012-04-12       Impact factor: 2.374

5.  Improved reproducibility of simple quantitative indices from ⁹⁹mTc-GSA liver functional imaging.

Authors:  Gou Ogasawara; Yusuke Inoue; Yoshihiro Itoh; Satomi Tagami; Keiji Matsunaga; Kenji Miki
Journal:  Ann Nucl Med       Date:  2013-04-18       Impact factor: 2.668

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.